MAM
MPM Asset Management’s Dyne Therapeutics DYN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.5M | Hold |
682,376
| – | – | 14.99% | 2 |
|
|
2025
Q1 | $7.14M | Hold |
682,376
| – | – | 10.28% | 3 |
|
|
2024
Q4 | $16.1M | Hold |
682,376
| – | – | 12.92% | 3 |
|
|
2024
Q3 | $24.5M | Sell |
682,376
-879,120
| -56% | -$31.6M | 16.87% | 3 |
|
|
2024
Q2 | $55.1M | Sell |
1,561,496
-1,889,807
| -55% | -$66.7M | 30.26% | 2 |
|
|
2024
Q1 | $98M | Sell |
3,451,303
-1,500,000
| -30% | -$42.6M | 39.97% | 1 |
|
|
2023
Q4 | $65.9M | Hold |
4,951,303
| – | – | 32.36% | 2 |
|
|
2023
Q3 | $44.4M | Hold |
4,951,303
| – | – | 23.76% | 2 |
|
|
2023
Q2 | $55.7M | Hold |
4,951,303
| – | – | 27.32% | 2 |
|
|
2023
Q1 | $57M | Hold |
4,951,303
| – | – | 23.77% | 2 |
|
|
2022
Q4 | $57.4M | Hold |
4,951,303
| – | – | 24.01% | 2 |
|
|
2022
Q3 | $62.9M | Hold |
4,951,303
| – | – | 23.95% | 2 |
|
|
2022
Q2 | $34M | Hold |
4,951,303
| – | – | 14.35% | 3 |
|
|
2022
Q1 | $47.7M | Hold |
4,951,303
| – | – | 16.31% | 2 |
|
|
2021
Q4 | $58.9M | Hold |
4,951,303
| – | – | 12.72% | 3 |
|
|
2021
Q3 | $80.4M | Hold |
4,951,303
| – | – | 18.64% | 2 |
|
|
2021
Q2 | $104M | Hold |
4,951,303
| – | – | 19.37% | 1 |
|
|
2021
Q1 | $76.9M | Hold |
4,951,303
| – | – | 14.86% | 4 |
|
|
2020
Q4 | $104M | Hold |
4,951,303
| – | – | 14.71% | 3 |
|
|
2020
Q3 | $100M | Buy |
+4,951,303
| New | +$100M | 18.64% | 1 |
|